Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)
As the Dow hits another all time record high this year at 15,688.36 Wednesday, Oct 30, 2013, 10:31 AM EDT, I would like to guide your attention to a company that currently experiencing a 48.67% gain Wednesday, Oct 30, 2013 10:26AM EDT. This Company that develops medical products that efficiently deliver oxygen to tissues in the body goes by the name of Oxygen Biotherapeutics stock symbol OXBT. This Company is up +0.73 and thus far doesn’t show any sign of slowing down. So why is this hot stock Company experiencing over 4.10 million shares in play, smashing their 3 month average you ask. The answer is levosimendan.
Levosimendan is a calcium sensitizer created for intra-venous use in hospitalized patients with acutely decompensated heart failure. This Wednesday Phyxius Pharma and Oxygen Biotherapeutics announced that researchers at the Duke Clinical Research Institute reported findings of a meta-analysis of multiple clinical trials that evaluated the use of levosimendan in patients undergoing heart surgery. These findings showed that levosimendan was associated with reduced mortality (death) and other adverse outcomes including heart attacks during and after operation in patients with reduced heart function undergoing heart surgery. You can view this publication at http://www.jcvaonline.com/article/S1053-0770(13)00171-7/abstract.
What makes this into a more succulent dish is that Oxygen Biotherapeutics stock symbol OXBT (www.oxybiomed.com) has a Definitive Agreement to acquire certain assets of Phyxius Pharma, including the U.S. and Canadian development and commercialization rights to levosimendan. The stock is at $2.23 with a market cap of 11.31 million.
Crown Equity Holdings Inc. (OTCMKTS:CRWE)
Around the world people are becoming more dependent on their internet access. Some like to find out information on particular educational subjects and some like to buy and sale products. iB2BGlobal is in the the process of making it a reality. iB2BGlobal is a B2B trade online directory for a various amount international manufacturers. As e-commerce volume continues to grow at a astronomical rate, iB2BGlobal has the potential to grow, as online retail businesses continue to search for a more simplified way to reach their consumers by internet touch points access.
Now what makes Crown Equity Holdings Inc. stock symbol CRWE (www.crownequityholdings.com) important, is that they have founded iB2BGlobal. In a recent Short Form Business Plan, iB2BGlobal predicted that their Company should collect around $10 million to $15 million in total EBITA by the end of their third business year. Assumptionally, this would be determined by the power of partnerships, competitive advantages, merchants, brands and retailers etc. Read iB2BGlobal Short Form Business Plan here http://crownequityholdings.com/extras/iB2BGlobal_business_plan.pdf. The stock is at $0.01 with a market cap of 8.80 million.
Remember: Always do your homework and consult your own financial professional.
Read Full Disclaimer @ http://crweselect.com/disclaimer